Sage Therapeutics Inc (NAS:SAGE)
$ 11.09 0.46 (4.31%) Market Cap: 667.42 Mil Enterprise Value: -72.17 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 46/100

SAGE Therapeutics Inc at Wolfe Research Healthcare Conference (Virtual) Transcript

Nov 19, 2020 / 09:05PM GMT
Release Date Price: $74.93 (+2.78%)
Akash Tewari
Wolfe Research, LLC - Director of Equity Research & Senior Research Analyst

Good afternoon, everyone. I hope everyone is having a good second annual Wolfe Healthcare Conference. I know I am. I have the pleasure of hosting Sage's management team, including Steve Kanes, Chief Medical Officer; and Kimi Iguchi, Chief Financial Officer. We are going to dig into, obviously, SAGE-217, but also 718, 324, and also kind of the catalyst path going into next year. I think one thing that stands out to me is you have so many readouts even in the next 6 months that people aren't maybe paying enough attention to.

So I'll leave the floor open to you both if you want to make any opening remarks, and then we'll take it from there. Thank you.

Kimi E. Iguchi
Sage Therapeutics, Inc. - CFO & Treasurer

Yes. Well, why don't I kick it off? And thanks, Akash, for having us. This has been a great -- terrific day for us. Steve and I are delighted to be here and delighted to give you an update on Sage. And so we've made a lot of progress this year. So we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot